<DOC>
	<DOC>NCT02268812</DOC>
	<brief_summary>This is an open-label, long-term, multi-centre multi-national postmarketing observational registry. The objective of this study is to monitor the long-term efficacy, safety, tolerability and quality of life outcomes associated with Prialt and other analgesics utilised in the intrathecal management of severe chronic pain.</brief_summary>
	<brief_title>Patient Registry of Intrathecal Pain Management in Europe for Prialt (Ziconotide Intrathecal Infusion) and Alternative Drugs for the Management of Severe, Chronic Pain.</brief_title>
	<detailed_description>This is an obsevational non-interventional registry. All patients will sign and date an Informed Consent Form (ICF) before enrolment (Baseline Visit). Normal clinical practice will be followed. Patients will continue to follow their usual schedule of clinic visits as determined by their physician, during which information and patient-completed questionnaires will be collected (at scheduled intervals timed to coincide with pump refill). The post-baseline assessment schedule is expected to be at 6 weeks, 4 months, and then every 4 months thereafter.</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Ziconotide</mesh_term>
	<criteria>Inclusion Criteria Patients will be eligible to enrol onto the registry if they have given informed consent andmeet the following criteria: Patient's physician has deemed that the initiation/switch of intrathecal analgesia appropriate, or patient is presently utilising Prialt Patient has a diagnosis of severe, chronic pain for which intrathecal infusion is indicated Patient is at least 18 years of age at time of study entry All patients starting Prialt should comply with the indications and warnings in the current approved version of the Summary of Product Characteristics (SmPC). Exclusion Criteria Patients who meet any of the following criteria will not be eligible to enrol in the registry: Patient is a pregnant or lactating female Patient is receiving intrathecal chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Pain Management</keyword>
	<keyword>Europe</keyword>
	<keyword>Intrathecal</keyword>
</DOC>